Table 1.
DN % ± SEM (# × 106) |
DP % ± SEM (# × 106) |
CD8 SP % ± SEM (# × 106) |
CD4 SP % ± SEM (# × 106) |
PLZF+ % ± SEM (# × 105)* |
CD1d tet+ % ± SEM (# × 105)* |
|
---|---|---|---|---|---|---|
WT C57BL/6 N=6 (95.9×106 ±3.85) | 4.99±0.47 (4.79±0.57) |
80.9±0.29 (77.6±2.17) |
2.97±0.11 (2.84±0.16) |
9.47±0.23 (9.08±0.42) |
1.33±0.14 (1.21±0.18) |
1.85±0.05 (1.53±0.12) |
Slamf6−/− N=6 (96.5×106 ±6.6) | 4.98±0.47 (4.78±0.48) |
81.8±1.14 (79.1±2.49) |
2.64±0.37 (2.55±0.33) |
8.91±0.84 (8.6±0.8) |
0.42±0.01 (0.36±0.02) |
1.06±0.07 (0.91±0.08) |
WT C57BL/6# N=9 (71.7×106 ±6.31) | 3.08±0.26 (2.21±0.26) |
87.2±1.38 (62.5±3.2) |
1.46±0.18 (1.05±0.15) |
5.23±0.79 (3.75±0.63) |
0.76±0.18 (0.29±0.09) |
0.9±0.11 (0.34±0.06) |
B6.Sle1b N=9 (99.5×106 ±5.44) | 3.63±0.66 (3.61±0.64) |
84.9±3.7 (84.5±6.61) |
2.43±0.59 (2.42±0.57) |
5.53±0.48 (5.5±0.58) |
1.91±0.24 (1.11±0.08) |
1.44±0.17 (0.79±0.15) |
Percentages are of gated CD4 single positive cells.
Controls for B6.Sle1b experiments (performed at a different time)